The Claim
A 12-week low-carbohydrate energy-restricted diet in adults with type 2 diabetes and obesity reduces plasma metabolites associated with hepatic insulin resistance, including diacylglycerols, ceramides, and various phospholipids (114 metabolites altered, p<0.05), supporting improvements in liver metabolic function observed through clinical indices.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When people with type 2 diabetes and obesity follow a low-carb diet for 12 weeks, it changes certain blood chemicals that are linked to liver problems, which helps improve how their liver works.
See the scientific wording
A 12-week low-carbohydrate energy-restricted diet in adults with type 2 diabetes and obesity reduces plasma metabolites associated with hepatic insulin resistance, including diacylglycerols, ceramides, and various phospholipids (114 metabolites altered, p<0.05), supporting improvements in liver metabolic function observed through clinical indices.
What the research says
1 studyThe study tested the same low-carb diet as the claim and found it reduced harmful fats in the blood and improved liver health in people with diabetes, which supports the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.